Literature DB >> 26330688

A Lipidomic Readout of Disease Progression in A Diet-Induced Mouse Model of Nonalcoholic Fatty Liver Disease.

Arun J Sanyal, Tommy Pacana.   

Abstract

Multiple changes in lipid metabolism occur in nonalcoholic fatty liver disease. However, it is not known which of these contribute to disease progression. The objective of this study was to define changes in hepatic lipid composition over time in a diet-induced model of nonalcoholic fatty liver disease to identify changes associated with disease progression. A lipidomic approach was used to quantify individual lipid species with lipid classes of interest including diacylglycerols (DAG), cholesterol, phospholipids, plasmalogens, sphingolipids, and eicosanoids. C57b/S129J mice fed a high-fat, high-cholesterol diet developed fatty liver, inflammation, and ballooning by 16 weeks and extensive fibrosis by week 52. There was a marked increase in monounsaturated fatty acid containing DAGs and cholesterol esters by week 16 which decreased by week 52. The changes in DAG were associated with a 500- to 600-fold increase in phosphatidic acid (< 0.001) and its downstream product phosphatidylglycerol (P <0.01) whereas phosphatidylethanolamine, phosphatidylcholine, and phsophatidylserine all decreased. Disease progression was associated with a significant further decrease in phosphatidylcholine and phosphatidylethanolamine while several lysolecithin species increased. Disease progression was associated with a significant increase in the plasmalogen PC-P 16:0/16:1. Saturated fatty acid (16:0 and 18:0) containing ceramides, sphingosine, sphingosine-1-phosphate, dihydrosphingosine, and dihydrophingosine-1-phosphate increased by week 16 after high-fat high-cholesterol diet. Globotrioseacylceramide (GB3) also increased significantly by week 16 and increased further with disease progression. 12-hydroxyeicosatetranoic acid decreased at week 16 but increased with disease progression. In conclusion, multiple lipids were associated with disease progression and provide clues regarding lipid drivers of nonalcoholic steatohepatitis.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26330688      PMCID: PMC4530706     

Source DB:  PubMed          Journal:  Trans Am Clin Climatol Assoc        ISSN: 0065-7778


  42 in total

1.  A position statement on NAFLD/NASH based on the EASL 2009 special conference.

Authors:  Vlad Ratziu; Stefano Bellentani; Helena Cortez-Pinto; Chris Day; Giulio Marchesini
Journal:  J Hepatol       Date:  2010-05-07       Impact factor: 25.083

2.  Innate immune reactivity of the ileum-liver axis in nonalcoholic steatohepatitis.

Authors:  Tatsuhiro Tsujimoto; Hideto Kawaratani; Toshiyuki Kitazawa; Masahito Uemura; Hiroshi Fukui
Journal:  Dig Dis Sci       Date:  2012-02-25       Impact factor: 3.199

3.  Fatty acid and endotoxin activate inflammasomes in mouse hepatocytes that release danger signals to stimulate immune cells.

Authors:  Timea Csak; Michal Ganz; Justin Pespisa; Karen Kodys; Angela Dolganiuc; Gyongyi Szabo
Journal:  Hepatology       Date:  2011-07       Impact factor: 17.425

Review 4.  High-throughput shotgun lipidomics by quadrupole time-of-flight mass spectrometry.

Authors:  Marcus Ståhlman; Christer S Ejsing; Kirill Tarasov; Jeanna Perman; Jan Borén; Kim Ekroos
Journal:  J Chromatogr B Analyt Technol Biomed Life Sci       Date:  2009-02-24       Impact factor: 3.205

5.  The methionine-choline deficient dietary model of steatohepatitis does not exhibit insulin resistance.

Authors:  Mary E Rinella; Richard M Green
Journal:  J Hepatol       Date:  2004-01       Impact factor: 25.083

6.  Saturated fatty acids induce endoplasmic reticulum stress and apoptosis independently of ceramide in liver cells.

Authors:  Yuren Wei; Dong Wang; Farran Topczewski; Michael J Pagliassotti
Journal:  Am J Physiol Endocrinol Metab       Date:  2006-02-21       Impact factor: 4.310

Review 7.  The role of fatty acids in the development and progression of nonalcoholic fatty liver disease.

Authors:  Christopher L Gentile; Michael J Pagliassotti
Journal:  J Nutr Biochem       Date:  2008-04-21       Impact factor: 6.048

8.  Role of liver-infiltrating CD3+CD56+ natural killer T cells in the pathogenesis of nonalcoholic fatty liver disease.

Authors:  Kazuto Tajiri; Yukihiro Shimizu; Koichi Tsuneyama; Toshiro Sugiyama
Journal:  Eur J Gastroenterol Hepatol       Date:  2009-06       Impact factor: 2.566

9.  Charting molecular composition of phosphatidylcholines by fatty acid scanning and ion trap MS3 fragmentation.

Authors:  Kim Ekroos; Christer S Ejsing; Ute Bahr; Michael Karas; Kai Simons; Andrej Shevchenko
Journal:  J Lipid Res       Date:  2003-08-16       Impact factor: 5.922

10.  Globotriaosylceramide, Gb3, is an alternative functional receptor for Shiga-like toxin 2e.

Authors:  G T Keusch; M Jacewicz; D W Acheson; A Donohue-Rolfe; A V Kane; R H McCluer
Journal:  Infect Immun       Date:  1995-03       Impact factor: 3.441

View more
  22 in total

1.  PET/CT with 18F Fluorocholine as an Imaging Biomarker for Chronic Liver Disease: A Preliminary Radiopathologic Correspondence Study in Patients with Liver Cancer.

Authors:  Sandi A Kwee; Linda Wong; Owen T M Chan; Sumodh Kalathil; Naoky Tsai
Journal:  Radiology       Date:  2018-01-09       Impact factor: 11.105

Review 2.  Sphingosine kinase and sphingosine-1-phosphate in liver pathobiology.

Authors:  Timothy Rohrbach; Michael Maceyka; Sarah Spiegel
Journal:  Crit Rev Biochem Mol Biol       Date:  2017-06-15       Impact factor: 8.250

3.  FTY720/fingolimod decreases hepatic steatosis and expression of fatty acid synthase in diet-induced nonalcoholic fatty liver disease in mice.

Authors:  Timothy D Rohrbach; Amon Asgharpour; Melissa A Maczis; David Montefusco; L Ashley Cowart; Pierre Bedossa; Arun J Sanyal; Sarah Spiegel
Journal:  J Lipid Res       Date:  2019-05-20       Impact factor: 5.922

Review 4.  Metabolomic and Lipidomic Biomarkers for Premalignant Liver Disease Diagnosis and Therapy.

Authors:  Diren Beyoğlu; Jeffrey R Idle
Journal:  Metabolites       Date:  2020-01-28

5.  Injury to hypothalamic Sim1 neurons is a common feature of obesity by exposure to high-fat diet in male and female mice.

Authors:  Eugene Nyamugenda; Marcus Trentzsch; Susan Russell; Tiffany Miles; Gunnar Boysen; Kevin D Phelan; Giulia Baldini
Journal:  J Neurochem       Date:  2019-02-11       Impact factor: 5.372

6.  Manifold Roles of Ceramide Metabolism in Non-Alcoholic Fatty Liver Disease and Liver Cancer.

Authors:  Kai Wang; Yiran Wei; Ruijuan Xu; Yiyi Li; Cungui Mao
Journal:  Adv Exp Med Biol       Date:  2022       Impact factor: 2.622

Review 7.  Non-alcoholic fatty liver disease: Insights from sphingolipidomics.

Authors:  David J Montefusco; Jeremy C Allegood; Sarah Spiegel; L Ashley Cowart
Journal:  Biochem Biophys Res Commun       Date:  2018-05-21       Impact factor: 3.575

8.  Intake of stigmasterol and β-sitosterol alters lipid metabolism and alleviates NAFLD in mice fed a high-fat western-style diet.

Authors:  Simin Feng; Zhuqing Dai; Anna B Liu; Jinbao Huang; Nihal Narsipur; Grace Guo; Bo Kong; Kenneth Reuhl; Wenyun Lu; Zisheng Luo; Chung S Yang
Journal:  Biochim Biophys Acta Mol Cell Biol Lipids       Date:  2018-08-07       Impact factor: 4.698

9.  Identification of a Metabolic, Transcriptomic, and Molecular Signature of Patatin-Like Phospholipase Domain Containing 3-Mediated Acceleration of Steatohepatitis.

Authors:  Bubu A Banini; Divya P Kumar; Hae-Ki Min; Arun J Sanyal; Sophie Cazanave; Mulugeta Seneshaw; Faridoddin Mirshahi; Prasanna K Santhekadur; Liangsu Wang; Hong Ping Guan; Abdul M Oseini; Cristina Alonso; Pierre Bedossa; Srinivas V Koduru
Journal:  Hepatology       Date:  2021-03-19       Impact factor: 17.425

Review 10.  Nonalcoholic Fatty Liver Disease and Hypercholesterolemia: Roles of Thyroid Hormones, Metabolites, and Agonists.

Authors:  Rohit A Sinha; Eveline Bruinstroop; Brijesh K Singh; Paul M Yen
Journal:  Thyroid       Date:  2019-09       Impact factor: 6.568

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.